Psoriasis: Is the impairment to a patient's life cumulative?

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 9, 2010, Pages 989-1004

  Kimball, A B ^a   Gieler, U ^b   Linder, D ^c   Sampogna, F ^d   Warren, Rb ^e   Augustin, M ^f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

coping strategies; Cumulative Life Course Impairment; physical co morbidities; psoriasis; psychological co morbidities; stigma

Indexed keywords

CASE CONTROL STUDY; CLINICAL ASSESSMENT; COMORBIDITY; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; HEALTH SURVEY; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW;

ADAPTATION, PSYCHOLOGICAL; HUMANS; PSORIASIS; QUALITY OF LIFE; STEREOTYPING;

EID: 77955262020     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03705.x     Document Type: Review

References (82)

1. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med 1995 332 : 581 588.
2. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007 370 : 263 271.
3. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008 128 : 1207 1211.
4. Alexandroff AB, Pauriah M, Camp RDR et al. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 2009 161 : 1 7.
5. Kimball AB, Gladman D, Gelfand JM et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008 58 : 1031 1042.
6. Kimball AB, Guerin A, Mulani P, Gupta S. The risk of coronary heart disease and stroke among psoriasis patients. JAAD 2009 60 (Suppl. AB179.
7. Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn's disease. J Am Acad Dermatol 2003 48 : 805 821.
8. Reich K, Krüger K, Mössner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009 160 : 1040 1047.
9. Cohen AD, Sherf M, Vidavsky L et al. Association between psoriasis and the metabolic syndrome. Dermatology 2008 216 : 152 155.
10. Qureshi AA, Choi HK, Setty AR et al. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009 145 : 379 382.
11. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006 296 : 1735 1741.
12. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006 298 : 321 328.
13. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 835. (Pubitemid 44556851)
14. Gisondi P, Tessari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007 156 : 68 73.
15. Gisondi P, Targher G, Zoppini G, Girolomoni G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009 51 : 758 764.
16. Prodanovich S, Kirsner RS, Kravetz JD et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009 145 : 700 703.
17. Benoit S, Hamm H. Childhood psoriasis. Clin Dermatol 2007 25 : 555 562.
18. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schafer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010 162 : 633 636.
19. Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life. Arch Dermatol 2001 137 : 280 284.
20. Weiss SC, Kimball AB, Liewehr DJ et al. Quantifying the harmful effect of psoriasis on health-related quality of life. JAAD 2002 47 : 512 518.
21. Kimball AB, Jacobson C, Weiss S et al. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005 6 : 383 392.
22. Augustin M, Krüger K, Radtke MA et al. Disease severity, quality of life and healthcare in plaque-type psoriasis: a multicentre, cross-sectional study in Germany. Dermatology 2008 216 : 366 372.
23. Misery L, Thomas L, Jullien D et al. Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatology. Eur J Dermatol 2008 18 : 412 415.
24. Zachariae R, Zachariae C, Ibsen H et al. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol 2000 80 : 272 276.
25. Gulliver W. Long-term prognosis in patients with psoriasis. Br J Dermatol 2008 159 (Suppl. 2 2 9.
26. Gottlieb AB, Chao C, Dann F. Psoriasis comorbidities. J Dermatolog Treat 2008 19 : 5 21.
27. Ginsburg IH, Link BG. Psychological consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol 1993 32 : 587 591.
28. Vardy D, Besser A, Amir M et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002 147 : 736 742.
29. Koo J. Population-based epidermatologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996 14 : 485 496.
30. Kleyn CE, McKie S, Ross AR et al. Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging study. J Invest Dermatol 2009 129 : 2613 2619.
31. Schmid-Ott G, Künsebeck H-W, Jäger B et al. Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol 2005 85 : 27 32.
32. Schmid-Ott G, Kuensebeck H-W, Jaeger B et al. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol 1999 79 : 443 447.
33. Schmid-Ott G, Burchard R, Niederauer HH et al. Stigmatization and quality of life of patients with psoriasis and atopi dermatitis [Stigmatisierung und Lebensqualität bei Patienten mit Psoriasis und Neurodermitis.] Der Hautarzt 2003 54 : 852 857 paper in German).
34. Fox FE, Rumsey N, Morris N. "Ur skin is the thing that everyone sees and you can't change it! ": exploring the appearance-related concerns of young people with psoriasis. Dev Neurorehabil 2007 10 : 133 141.
35. Sampogna F, Gisondi P, Tabolli S et al. Impairment of sexual life in patients with psoriasis. Dermatology 2007 214 : 144 150.
36. Lynde C, Guenther L, Poulin Y. The burden of psoriasis and psoriatic arthritis in Canada: insights from the psoriasis knowledge in Canada (SKIN) survey. JAAD 2009 60 (Suppl. AB165.
37. Waters HC, Carter CT, Piech CT et al. The impact of psoriasis on psychological functioning and quality of life. JAAD 2009 60 (Suppl. AB183.
38. Gupta MA, Schork N. Suicidal ideation in psoriasis. Int J Dermatol 1993 32 : 188 190.
39. Higgins EM, Peters TJ, du Vivier AWP. Smoking, drinking and psoriasis. Br J Dermatol 1993 129 : 749 750.
40. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999 35 : 1490 1493.
41. Kirby B, Richards HL, Mason DL et al. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 2008 158 : 138 140.
42. Sampogna F, Picardi A, Chren M-M et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med 2004 66 : 620 624.
43. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003 4 : 833 842.
44. Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005 64 (Suppl. 2 ii18 ii23.
45. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009 65 : 732 741.
46. Arck P, Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 2006 13 : 347 356.
47. Saraceno R, Kleyn CE, Terenghi G, Griffiths CEM. The role of neuropeptides in psoriasis. Br J Dermatol 2006 155 : 876 882.
48. Kleyn CE, Schneider L, Saraceno R et al. The effects of acute social stress on epidermal langerhans' cell frequency and expression of cutaneous neuropeptides. J Invest Dermatol 2008 128 : 1273 1279.
49. Schmid-Ott G, Jacobs R, Jäger B et al. Stress induced endocrine and immunological changes in psoriasis patients and healthy controls. Psychother Psychosom 1998 67 : 37 42.
50. Schmid-Ott G, Jaeger B, Adamek C et al. Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopy dermatitis. J Allergy Clin Immunol 2001 107 : 171 177.
51. Schaaf H, Eipp C, Deubner R et al. [Psychosocial aspects of coping with tinnitus and psoriasis patients. A comparative study of suicidal tendencies, anxiety and depression.] HNO 2009 57 : 57 63. (article in German)
52. Chaput J-C, Poynard T, Naveau S et al. Psoriasis, alcohol, and liver disease. Br Med J 1985 291 : 25.
53. Niemeier V, Fritz J, Kupfer J, Gieler U. Aggressive verbal behaviour as a function of experimentally induced anger in persons with psoriasis. Eur J Dermatol 1999 9 : 555 558.
54. Mayer CU. New directions in life course research. Annu Rev Sociol 2009 35 : 413 433.
55. Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002 31 : 285 293.
56. Lynch J, Smith GD. A life course approach to chronic disease epidemiology. Annu Rev Public Health 2005 26 : 1 35.
57. Jobling R. Psoriasis. Br Med J 2007 334 : 953 954.
58. Finlay AY, Coles ECl. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995 132 : 236 244.
59. Schmitt JM, Ford DE. Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology 2006 213 : 102 110.
60. Horn EJ, Fox KM, Patel V et al. Association of patient-reported psoriasis severity with income and employment. JAAD 2007 57 : 963 971.
61. Sohn S, Schoeffski O, Prinz J et al. Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study. Dermatology 2006 212 : 137 144.
62. Frangos JE, Kimball AB. Divorce/marriage ratio in patients with psoriasis compared to patients with other chronic medical conditions. J Invest Dermatol 2008 128 (Suppl. 1 S87.
63. Eghlileb AM, Davies EEG, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 2007 156 : 1245 1250.
64. Scharloo M, Kaptein AA, Weinman J et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res 1998 44 : 573 585.
65. Scharloo M, Kaptein AA, Weinman JA et al. Predicting functional status in patients with rheumatoid arthritis. J Rheumatol 1999 26 : 1686 1693.
66. Hampson SE, Glasgow RE, Zeiss AM. Personal models of osteoarthritis and their relation to self-management activities and quality of life. J Behav Med 1994 17 : 143 158.
67. Petrie KJ, Weinman J, Sharpe N, Buckley J. Role of patients' view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. Br Med J 1996 312 : 1191 1194.
68. McCrae R, Costa PT. Personality, coping, and coping effectiveness in an adult sample. J Pers 2006 54 : 385 404.
69. Scharloo M, Kaptein AA, Weinman J et al. Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 2000 142 : 899 907.
70. Kupfer J, Niemeier V, Brosig B et al. Sense of coherence among psoriatics as a predictor of symptom-free time following dermatological inpatient therapy. Dermatol Psychosom 2003 4 : 200 206.
71. Fortune DG, Richards HL, Kirby B et al. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 2002 146 : 458 465.
72. Fortune DG, Richards HL, Griffiths CEM et al. Targeting cognitive-behaviour therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol 2004 43 : 65 83.
73. Hill L, Kennedy P. The role of coping strategies in mediating subjective disability in people who have psoriasis. Psychol Health Med 2002 7 : 261 269.
74. Brenninkmeijer EEA, Legieres CM, Sillevis Smitt JH et al. The course of life of patients with childhood atopic dermatitis. Pediatr Dermatol 2009 26 : 14 22.
75. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci USA 2001 98 : 4770 4775.
76. Von Korff M, Alonso J, Ormel J et al. Childhood psychosocial stressors and adult onset arthritis: broad spectrum risk factors and allostatic load. Pain 2009 143 : 76 83.
77. Esposito M, Saraceno R, Giunta A et al. An Italian study on psoriasis and depression. Dermatology 2006 212 : 123 127.
78. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998 139 : 846 850.
79. Fortune DG, Richards HL, Griffiths CE, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002 41 : 157 174.
80. Wolf N, Quaranta M, Prescott NJ et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet 2008 45 : 114 116.
81. Tobin AM, Higgins EM, Norris S, Kirby B. Prevalence of psoriasis in patients with alcoholic liver disease. Clin Exp Dermatol 2009 34 : 698 701.
82. Fortune DG, Richards HL, Kirby B et al. Epidemiology and health services research successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being. Br J Dermatol 2004 151 : 1219 1226.